Allianz Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.28M | Buy |
87,100
+9,500
| +12% | +$554K | 0.01% | 1137 |
|
|
2025
Q4 | $4.19M | Buy |
77,600
+20,500
| +36% | +$986K | ﹤0.01% | 1215 |
|
|
2025
Q3 | $2.58M | Sell |
57,100
-30,800
| -35% | -$1.44M | ﹤0.01% | 1399 |
|
|
2025
Q2 | $4.07M | Buy |
87,900
+36,300
| +70% | +$1.78M | ﹤0.01% | 1207 |
|
|
2025
Q1 | $3.15M | Buy |
51,600
+26,900
| +109% | +$1.57M | ﹤0.01% | 1305 |
|
|
2024
Q4 | $1.4M | Sell |
24,700
-36,300
| -60% | -$2.03M | ﹤0.01% | 1551 |
|
|
2024
Q3 | $3.16M | Buy |
61,000
+20,400
| +50% | +$957K | ﹤0.01% | 1240 |
|
|
2024
Q2 | $1.69M | Buy |
40,600
+38,400
| +1,745% | +$1.72M | ﹤0.01% | 1387 |
|
|
2024
Q1 | $119K | Sell |
2,200
-58,500
| -96% | -$2.98M | ﹤0.01% | 1906 |
|
|
2023
Q4 | $3.11M | Sell |
60,700
-83,400
| -58% | -$4.38M | 0.01% | 1134 |
|
|
2023
Q3 | $8.36M | Buy |
144,100
+74,500
| +107% | +$4.56M | 0.01% | 780 |
|
|
2023
Q2 | $4.45M | Sell |
69,600
-29,700
| -30% | -$1.99M | 0.01% | 918 |
|
|
2023
Q1 | $6.88M | Buy |
99,300
+22,900
| +30% | +$1.62M | 0.01% | 840 |
|
|
2022
Q4 | $5.5M | Buy |
76,400
+13,000
| +21% | +$980K | 0.01% | 878 |
|
|
2022
Q3 | $4.51M | Buy |
63,400
+45,300
| +250% | +$3.29M | 0.01% | 922 |
|
|
2022
Q2 | $1.39M | Sell |
18,100
-23,700
| -57% | -$1.81M | ﹤0.01% | 1556 |
|
|
2022
Q1 | $3.05M | Buy |
41,800
+14,300
| +52% | +$960K | ﹤0.01% | 1432 |
|
|
2021
Q4 | $1.72M | Sell |
27,500
-58,600
| -68% | -$3.44M | ﹤0.01% | 1666 |
|
|
2021
Q3 | $5.09M | Buy |
86,100
+60,500
| +236% | +$3.98M | ﹤0.01% | 1272 |
|
|
2021
Q2 | $1.71M | Buy |
+25,600
| New | +$1.67M | ﹤0.01% | 1527 |
|
|
2020
Q3 | – | Sell |
-115,400
| Closed | -$6.79M | – | 1920 |
|
|
2020
Q2 | $6.79M | Buy |
115,400
+800
| +0.7% | +$47.9K | 0.01% | 1061 |
|
|
2020
Q1 | $6.39M | Sell |
114,600
-10,700
| -9% | -$654K | 0.01% | 1039 |
|
|
2019
Q4 | $8.04M | Sell |
125,300
-17,400
| -12% | -$997K | 0.01% | 1267 |
|
|
2019
Q3 | $7.24M | Sell |
142,700
-7,500
| -5% | -$352K | 0.01% | 1269 |
|
|
2019
Q2 | $6.81M | Sell |
150,200
-200
| -0.1% | -$9.32K | 0.01% | 1358 |
|
|
2019
Q1 | $7.18M | Sell |
150,400
-133,700
| -47% | -$6.66M | 0.01% | 1289 |
|
|
2018
Q4 | $14.8M | Sell |
284,100
-76,300
| -21% | -$4.1M | 0.02% | 888 |
|
|
2018
Q3 | $22.4M | Sell |
360,400
-76,900
| -18% | -$4.56M | 0.02% | 827 |
|
|
2018
Q2 | $24.2M | Buy |
437,300
+308,200
| +239% | +$16.6M | 0.02% | 769 |
|
|
2018
Q1 | $8.17M | Sell |
129,100
-292,700
| -69% | -$18.8M | 0.01% | 1340 |
|
|
2017
Q4 | $25.8M | Buy |
421,800
+178,300
| +73% | +$11.2M | 0.02% | 862 |
|
|
2017
Q3 | $15.5M | Buy |
243,500
+56,800
| +30% | +$3.32M | 0.01% | 1102 |
|
|
2017
Q2 | $10.4M | Sell |
186,700
-23,200
| -11% | -$1.26M | 0.01% | 1293 |
|
|
2017
Q1 | $11.4M | Sell |
209,900
-205,000
| -49% | -$11.2M | 0.01% | 1275 |
|
|
2016
Q4 | $24.2M | Buy |
414,900
+80,600
| +24% | +$4.41M | 0.02% | 895 |
|
|
2016
Q3 | $18M | Buy |
334,300
+127,800
| +62% | +$8.21M | 0.02% | 1027 |
|
|
2016
Q2 | $15.2M | Buy |
206,500
+112,100
| +119% | +$7.92M | 0.02% | 1048 |
|
|
2016
Q1 | $6.03M | Buy |
94,400
+26,700
| +39% | +$1.68M | 0.01% | 1370 |
|
|
2015
Q4 | $4.66M | Buy |
67,700
+42,800
| +172% | +$2.83M | 0.01% | 1388 |
|
|
2015
Q3 | $1.47M | Sell |
24,900
-99,100
| -80% | -$6.29M | ﹤0.01% | 1691 |
|
|
2015
Q2 | $8.25M | Buy |
124,000
+67,700
| +120% | +$4.46M | 0.01% | 1182 |
|
|
2015
Q1 | $3.63M | Sell |
56,300
-24,600
| -30% | -$1.54M | ﹤0.01% | 1339 |
|
|
2014
Q4 | $4.78M | Buy |
80,900
+59,200
| +273% | +$3.34M | 0.01% | 1235 |
|
|
2014
Q3 | $1.11M | Buy |
+21,700
| New | +$1.08M | ﹤0.01% | 1633 |
|
Other funds holding BMY
VCM
VPM
Allianz Asset Management's BMY Position: Q1 2026 in Review
Allianz Asset Management increased its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, buying an estimated $80.7M and bringing the position to 6,879,864 shares worth $417M. The position accounts for 0.44% of the portfolio, ranked #37.
Allianz Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $477M in Q4 2019. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Allianz Asset Management held 6,879,864 shares of Bristol-Myers Squibb worth $417M as of Q1 2026.
- Allianz Asset Management bought 1,384,478 Bristol-Myers Squibb shares in Q1 2026, an estimated $80.7M.
- Bristol-Myers Squibb made up 0.44% of Allianz Asset Management's portfolio in Q1 2026, its #37 holding.
- Allianz Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Bristol-Myers Squibb position peaked at $477M in Q4 2019.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.